STUDY OF MICROALBUMINURIA AS A CARDIOMETABOLIC RISK FACTOR IN TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY.

Sugatha  Sahu; Bidyut Prava  Satpathy; Pushpanjali  Behera

doi:10.51168/sjhrafrica.v5i12.1417

Authors

Sugatha Sahu Assistant Professor, Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India
Bidyut Prava Satpathy Assistant Professor, Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India
Pushpanjali Behera Assistant Professor, Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.51168/sjhrafrica.v5i12.1417

Keywords:

Type 2 Diabetes Mellitus, Microalbuminuria, Glucose Levels, Cardiovascular Complications

Abstract

Background

The rising occurrence of type 2 diabetes mellitus (T2DM) presents considerable health hazards, particularly concerning heart-related complications. The presence of microalbuminuria acts as an important indicator for the early identification of vascular injury and cardiometabolic risks in individuals with T2DM, emphasizing the necessity for regular screening.

Aims

This work aims to assess the prevalence of microalbuminuria in individuals with type 2 diabetes mellitus in patients residing in Odisha.

Methods

This cross-sectional study took place for over 2.5 years at MKCG Medical College and Hospital, involving 110 patients diagnosed with T2DM. Participants were recruited from the outpatient and inpatient departments of General Medicine and Endocrinology, after obtaining informed consent. Comprehensive demographic and clinical data were collected, alongside laboratory assessments for microalbuminuria using an immunoassay method.

Results

The study comprised 65 males and 45 females, with an average age of 57.07 years. Microalbuminuria was found in 24 of 27 patients (88.89%) with diabetes for 11 years or more (p < 0.05). Additionally, 25 of 41 patients (61%) with elevated HbA1C levels had microalbuminuria. Mean fasting blood sugar was significantly higher in the microalbuminuria group (142.83 ± 37.32 mg/dL vs. 127.85 ± 31.36 mg/dL).

Conclusion

Microalbuminuria is significantly associated with the duration of diabetes, poor glycemic control, dyslipidemia, and renal dysfunction in patients with type 2 diabetes mellitus.

Recommendation:

Microalbuminuria is a marker of vascular disease and can be used to support further therapy directed at this complication. For the stated reasons, microalbuminuria testing is recommended.

References

Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. International journal of molecular sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275

Banday, M. Z., Sameer, A. S., & Nissar, S. (2020). Pathophysiology of diabetes: An overview. Avicenna journal of medicine, 10(4), 174–188. https://doi.org/10.4103/ajm.ajm_53_20

World Health Organization. (2023, April 5). Diabetes. World Health Organisation; WHO. https://www.who.int/news-room/fact-sheets/detail/diabetes

Pradeepa, R., & Mohan, V. (2021). Epidemiology of type 2 diabetes in India. Indian journal of ophthalmology, 69(11), 2932–2938. https://doi.org/10.4103/ijo.IJO_1627_21

Asghar, S., Asghar, S., Mahmood, T., Bukhari, S. M. H., Mumtaz, M. H., & Rasheed, A. (2023). Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications. Cureus, 15(8), e43190. https://doi.org/10.7759/cureus.43190

Bae, E. S., Hur, J. Y., Jang, H. S., Kim, J. S., & Kang, H. S. (2023). Risk Factors of Microalbuminuria among Patients with Type 2 Diabetes Mellitus in Korea: A Cross-Sectional Study Based on 2019-2020 Korea National Health and Nutrition Examination Survey Data. International journal of environmental research and public health, 20(5), 4169. https://doi.org/10.3390/ijerph20054169

Yang C.W., Park J.T., Kim Y.S., Kim Y.L., Lee Y.S., Oh Y.S., Kang S.W. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: Data from the Korean Epidemiology Study on Hypertension III (KEY III study) Nephrol. Dial. Transplant. 2011; 26:3249–3255. doi: 10.1093/ndt/gfr011.

Sukhram S.D., Zarini G.G., Shaban L.H., Vaccaro J.A., Huffman F.G. Microalbuminuria and hypertension among immigrants with type 2 diabetes: A community-based cross-sectional study. J. Pers. Med. 2022; 12:1777. Doi: 10.3390/jpm12111777.

Pradhan, P., Sanjeev Supakar, Nayak, S., Lipika Behera, & Jaya Kshatri. (2022). Prevalence of diabetes in Odisha, India: A systematic review and meta-analysis. Journal of Diabetology, 13(3), 227–227. https://doi.org/10.4103/jod.jod_53_22

Jyotsna, F., Ahmed, A., Kumar, K., Kaur, P., Chaudhary, M. H., Kumar, S., Khan, E., Khanam, B., Shah, S. U., Varrassi, G., Khatri, M., Kumar, S., & Kakadiya, K. A. (2023). Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes. Cureus, 15(8), e43882. https://doi.org/10.7759/cureus.43882

Ghimire B, Sakiewicz AJ. Management of Cardiovascular and Diabetes Risks Based on National Guidelines. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK580534/

Chowta, N. K., Pant, P., & Chowta, M. N. (2009). Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance. Indian journal of nephrology, 19(2), 53–56. https://doi.org/10.4103/0971-4065.53322

Sigdel, M., Rajbhandari, N., Basnet, S., Nagila, A., Basnet, P., & Tamrakar, B. K. (2008). Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal. Nepal Medical College journal: NMCJ, 10(4), 242–245.

Raman P.G., Hussain R, Taisankar K. Prevalence of microalbuminuria in diabetes mellitus and its correlation with various complications. J.Dial. Asso. India. 1996; 36 (3): 77-80.

Ravid, M., Brosh, D., Ravid-Safran, D., Levy, Z., & Rachmani, R. (1998). The main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Archives of internal medicine, 158(9), 998–1004. https://doi.org/10.1001/archinte.158.9.998

Phadnis, P., Kamble, M. A., Daigavane, S., Tidke, P., & Gautam, S. (2017). Prevalence and risk factors–Hemoglobin A1c, serum magnesium, lipids, and microalbuminuria for diabetic retinopathy: A rural Hospital-based study. Journal of Datta Meghe Institute of Medical Sciences University, 12(2), 121-132.

Lamba IMS, Sircar S, Taneja V, Kansra UU. Microalbuminuria in normotensive non-insulin-dependent diabetic subjects – Association and prediction. J. Diab. Assoc. 1997; 37(2):32-36.

Dadhania, B. P., Aravat, A. H., & Dhruva, G. A. (2012). Study of microalbuminuria in Diabetes Type 2 patients as a marker of morbidity (A study of 100 cases in Rajkot city). International Journal of Biomedical and Advance Research, 3(10). https://doi.org/10.7439/ijbar.v3i10.769

Ghosh, S., Lyaruu, I., & Yeates, K. (2012). Prevalence and factors associated with microalbuminuria in type 2 diabetic patients at a diabetes clinic in northern Tanzania. African Journal of Diabetes Medicine, 20(2).

Gerstein, H. C., Mann, J. F., Yi, Q., Zinman, B., Dinneen, S. F., Hoogwerf, B., Hallé, J. P., Young, J., Rashkow, A., Joyce, C., Nawaz, S., Yusuf, S., & HOPE Study Investigators (2001). Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA, 286(4), 421–426. https://doi.org/10.1001/jama.286.4.421

Ingelsson, E., Sundström, J., Lind, L., Risérus, U., Larsson, A., Basu, S., & Arnlöv, J. (2007). Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. European Heart Journal, 28(14), 1739–1745. https://doi.org/10.1093/eurheartj/ehm130